You are here

  • Home
  • Archive
  • Volume 79, Issue Suppl 1
  • OP0226 NETAKIMAB DECREASES DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED DOUBLE-BLIND PHASE 3 CLINICAL TRIAL (PATERA)

Article metrics

Article menu

Download PDFPDF

Scientific Abstracts
Oral Presentations
Update on new treatment options for psoriatic arthritis
OP0226 NETAKIMAB DECREASES DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED DOUBLE-BLIND PHASE 3 CLINICAL TRIAL (PATERA)
Free

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2024

AbstractFullPdf
Jun 20205808
Jul 20203302
Aug 20202804
Sep 20204105
Oct 20201200
Nov 20201102
Dec 20202505
Jan 20212106
Feb 20212808
Mar 20217404
Apr 202144010
May 20211408
Jun 2021006
Jul 2021009
Aug 20213015
Sep 20213013
Oct 202143016
Nov 202158021
Dec 20214606
Jan 20221603
Feb 20224903
Mar 202258012
Apr 202268011
May 20225505
Jun 20222305
Jul 20224106
Aug 20225905
Sep 20226608
Oct 20228004
Nov 20224208
Dec 20225206
Jan 20233106
Feb 20234103
Mar 202342012
Apr 20236909
May 20235603
Jun 202327010
Jul 202343012
Aug 202376014
Sep 20233108
Oct 20233307
Nov 20231901
Dec 20232707
Jan 20241101
Feb 20244704
Mar 202438015
Total17420336